Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan-Feb;41(1):78-85.
doi: 10.1590/S1677-5538.IBJU.2015.01.11.

Stage IIA and IIB testicular seminoma treated postorchiectomy with radiation therapy versus other approaches: a population-based analysis of 241 patients

Kamran A Ahmed  1 , Richard B Wilder  1
Affiliations

Stage IIA and IIB testicular seminoma treated postorchiectomy with radiation therapy versus other approaches: a population-based analysis of 241 patients

Kamran A Ahmed et al. Int Braz J Urol. 2015 Jan-Feb.

Abstract

Objectives: To evaluate post-orchiectomy utilization of radiation therapy (RT) versus other management approaches in stage IIA and IIB testicular seminoma patients.

Materials and methods: Two hundred and forty-one patients with stage IIA and IIB testicular seminoma were identified between 1988 and 2003 using the Surveillance, Epidemiology, and End Results (SEER) database.

Results: Median follow-up was 10 years. Patients with stage IIA disease underwent RT more frequently than those with stage IIB disease (72 % vs. 46 %, respectively; P < 0.001). There was no significant change in RT utilization for stage IIA or IIB disease between 1988 and 2003 (P = 0.89).

Conclusions: Between 1988 and 2003, stage IIA patients underwent RT more often than stage IIB patients in the United States. There was no significant change in RT utilization for stage IIA or IIB disease during this time period. Based on reports describing excellent progression-free survival with cisplatin-based chemotherapy, this approach has increased in popularity since 2003 and may eventually become the most popular treatment approach for both stage IIA and IIB testicular seminoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Overall survival for stage IIA testicular seminoma patients managed with radiation therapy vs. other approaches.
Figure 2
Figure 2. Overall survival for stage IIB testicular seminoma patients managed with radiation therapy vs. other approaches.
See this image and copyright information in PMC

References

    1. Hoffman KE, Chen MH, Punglia RS, Beard CJ, D’Amico AV. Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma. J Clin Oncol. 2008;26:3937–3942. - PMC - PubMed
    1. Morton GC, Thomas GM. Testis. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK, editors. Principles and Practice of Radiation Oncology. 4th. Philadelphia: Lippincott, Williams & Wilkins; 2004. pp. 1763–1784.
    1. Chung PW, Bedard P. Stage II seminomas and nonseminomas. Hematol Oncol Clin North Am. 2011;25:529–541. - PubMed
    1. Warde P, Huddart R, Bolton D, Heidenreich A, Gilligan T, Fossa S. Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology. 2011;78(4):S435–S443. - PubMed
    1. Chung PW, Gospodarowicz MK, Panzarella T, Jewett MA, Sturgeon JF, Tew-George, et al. Stage II testicular seminoma: patterns of recurrence and outcome of treatment. Eur Urol. 2004;45:754–759. discussion 759-60. - PubMed

Publication types

MeSH terms